

Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as PCOS, is a condition in which the body produces an imbalance of reproductive and metabolic hormones, particularly higher-than-normal androgen levels. These hormonal and metabolic changes can affect ovarian function, menstrual cycles, fertility, and overall health. PMOS can present with a wide range of features involving multiple body systems. Metabolic features include obesity, insulin resistance, prediabetes or type 2 diabetes, high blood pressure, abnormal lipid levels, fatty liver disease, cardiovascular risk, and sleep apnoea. Reproductive manifestations include irregular periods, ovulatory dysfunction, infertility, pregnancy-related complications, and increased risk of endometrial cancer. Psychological features may include anxiety, depression, poor quality of life, and eating disorders. Dermatological manifestations commonly include acne, excessive hair growth (hirsutism), and hair thinning or alopecia due to androgen excess. According to the World Health Organization (WHO), PCOS affects an estimated 8–13% of women of reproductive age, and up to 70% of cases are undiagnosed. Therefore, early diagnosis with the PMOS (formerly PCOS) Advanced Package can aid in appropriate interventions and help prevent future complications.
The PMOS panel is designed to evaluate the endocrine, ovarian, and metabolic abnormalities associated with Polyendocrine Metabolic Ovarian Syndrome. HbA1c and HOMA-IR assess long-term glycemic status and insulin resistance, a central driver of metabolic dysfunction and androgen excess in PMOS. Lipid Profile evaluates dyslipidaemia and cardiometabolic risk. LH and FSH help assess neuroendocrine and ovulatory dysfunction, while AMH reflects ovarian reserve and disordered folliculogenesis commonly seen in PMOS. Total Testosterone, Free Testosterone, SHBG, and DHEAS evaluate biochemical hyperandrogenism and help identify ovarian and adrenal androgen excess contributing to acne, hirsutism, alopecia, and menstrual irregularities. Serum Prolactin is included to exclude hyperprolactinemia as a cause of menstrual and ovulatory disturbances. 17 Alpha Hydroxy Progesterone helps rule out non-classical congenital adrenal hyperplasia and other adrenal causes of hyperandrogenism. Thyroid Profile (FT3, FT4, and TSH) assesses thyroid dysfunction, which may mimic or worsen reproductive and metabolic abnormalities associated with PMOS.
You may get this test if you show symptoms suggestive of PMOS, such as irregular periods, abnormal hair growth, weight gain, hair loss, skin conditions such as acne, etc. It may also be done in individuals with risk factors for the condition, such as family history or obesity. Additionally, this package helps monitor treatment response in women already undergoing treatment for PMOS.
An overnight fasting (8 to 12 hours) is required, along with other preparations depending on the number of tests included in this package. You are required to submit all the samples that are part of this package during the sample collection itself. Additionally, inform your doctor about any medications or supplements that you may be taking before undergoing for the PMOS (formerly PCOS) Advanced Package as few of them may affect your test results, potentially requiring adjustments or temporary discontinuation before the test.
Talk to your doctor about your specific test results. The doctor might ask you to get additional tests done to determine the severity of your condition. After analyzing all th
The PMOS (formerly PCOS) Advanced Package is a holistic assessment of various health markers to understand the impact of PMOS on the body. Key tests included in this package are Dehydroepiandrosterone Sulphate, Anti-Mullerian Hormone (AMH), Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), Prolactin, Testosterone Total, Testosterone Free, Sex Hormone Binding Globulin (SHBG), and 17 Alpha Hydroxy Progesterone, along with metabolic assessments like HbA1c, HOMA IR; Insulin Resistance Index, Lipid Profile and Thyroid Profile Free (FT3, FT4 & TSH). This comprehensive evaluation not only highlights hormonal disruptions but also underscores the importance of managing metabolic health in women with PMOS.
By identifying potential issues early and providing tailored management strategies, the PMOS (formerly PCOS) Advanced Package empowers women to take control of their health and navigate the complexities of PMOS effectively.
A Dehydroepiandrosterone Sulphate measures the levels of dehydroepiandrosterone sulphate (DHEAS) in the blood. DHEAS is a steroid hormone that is present in both males and females. It is primarily produced by the adrenal glands, with smaller amounts produced by ovaries in females and testicles in males.
DHEAS plays a role in developing male secondary sexual characteristics at puberty. The body can convert it into more potent androgens like testosterone and androstenedione. Also, it can be converted into the female hormone estrogen.
A Dehydroepiandrosterone Sulphate helps diagnose and differentiate certain endocrine disorders, contributing to a comprehensive understanding of hormonal balance in the body.
Know more about Dehydroepiandrosterone Sulphate
The Testosterone Free measures the level of unattached or free testosterone in the blood. It is called free testosterone or free T because it is not attached to other molecules, especially proteins. The body actively uses free testosterone as signaling molecules that regulate metabolism and other cellular functions.
Know more about Testosterone Free
The PMOS (formerly PCOS) Advanced Package is done:
- To evaluate hormonal imbalances associated with PMOS.
- In women suffering from symptoms suggestive of PMOS, such as irregular periods, facial hair growth, unexplained weight gain, acne, skin darkening, and pain in the pelvis.
- In women with risk factors for PMOS, such as family history or obesity.
- In women facing issues in getting pregnant.
- To monitor response to treatment and adjust medications for PMOS as needed.
- To monitor the impact of PMOS on overall health, including the risk of diabetes, cardiovascular issues or thyroid disorders.
- To guide treatment options, lifestyle modifications, and fertility interventions if needed.
- Overnight fasting (8-12 hrs) is required. Do not eat or drink anything except water before the test.
- In females, the preferred sampling time is day 2 or 3 of the menstrual cycle for LH & FSH.
- Do not stop taking your thyroid medications on the day of the test unless otherwise advised by the doctor.
- For AMH-If you take hormonal birth control pills, consult your doctor as they can interfere with the results.






















